Search Results

Business

CITOXLAB SIGNS INVESTMENT AND PARTNERSHIP DEAL WITH EPO

Investment in the German CRO, specialized in the preclinical assessment of new anticancer drugs, strengthens Citoxlab’s pharmacology portfolio, which will benefit from many synergies with preclinical safety and biomarkers services already provided by Citoxlab

September 10, 2018

·

4 min read

Deals

Charles River Laboratories Completes the Acquisition of Citoxlab

Charles River Laboratories International, Inc. announced that it has completed the previously announced acquisition of Citoxlab for €448 million in cash, subject to customary closing adjustments.

April 29, 2019

·

3 min read

Deals

Charles River Laboratories Signs Binding Offer to Acquire Citoxlab

Charles River Laboratories International, Inc. announced that it has signed a binding offer to acquire Citoxlab for €448 million in cash, subject to customary closing adjustments.

February 13, 2019

·

11 min read

Business

Citoxlab appoints Christophe Berthoux as CEO, Europe

This appointment will further drive current and future development of Citoxlab’s European sites, which are already experiencing strong growth.

August 30, 2018

·

2 min read

Deals

Citoxlab Acquires Xenometrics, an American CRO Specialized in Preclinical Assessment of New Drug Candidates

This acquisition is the third one made by Citoxlab in North America further to the acquisition of the LAB Research Group and Accellab.

November 2, 2017

·

4 min read

Business

CiToxLAB North America Purchases New Facility In Montreal, Canada To Meet The Growing Demand For Bioanalysis And Biomarkers Services

CiToxLAB, a leading Contract Research Organization (CRO), announces the purchase of a new facility in Laval (Montreal, Canada) to meet the growing demand for bioanalysis and biomarkers services in support of preclinical and clinical programs, offering shorter lead times for development programs.

October 18, 2017

·

3 min read

Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology

May 29, 2024

·

3 min read

Business

CiToxLAB And Kaly-Cell Join Forces To Offer In Vitro And Ex Vivo Testing For Hepatotoxicity And Metabolism

June 16, 2017

·

4 min read